BlogCatalog User Feed: BioMedReports http://www.blogcatalog.com/user/BioMedReports Activity feed for BioMedReports http://www.blogcatalog.com/user/BioMedReportshttp://www.blogcatalog.com/images/usr/283412.gifBlogCatalog User Feed: BioMedReports Copyright 2005-2007 BlogCatalog.com Sun, 03 Jan 2010 05:11:45 -0600 f89426960b157fc22f2c0fd54b4eadf4 BioMedReports has published a new blog post: BioMed News Bytes: Antigenics, King, Shire, Delcath. http://www.blogcatalog.com/post/4650dda4eba4e89e036e548281051755 Wed, 21 Oct 2009 08:51:00 -0500 BioMedReports has published a new blog post: BioMed News Bytes: Antigenics, King, Shire, Delcath.

]]> 74b60fdcd9f9f63941d83b8a04971b89 BioMedReports has published a new blog post: BioMed News Bytes: Angiotech, BioSante, HGSI. http://www.blogcatalog.com/post/d5a4e61310696886cbaf1fdfecb46844 Tue, 20 Oct 2009 08:09:00 -0500 BioMedReports has published a new blog post: BioMed News Bytes: Angiotech, BioSante, HGSI.

]]> 095b6d63f82b2f2f99710ecc3ef256aa BioMedReports has published a new blog post: Celldex Therapeutics (NASDAQ: CLDX): Plenty of Cash and Pending Clinical Catalysts. http://www.blogcatalog.com/post/b37c4866465e45b8223485cca59ec6b2 Mon, 19 Oct 2009 19:27:00 -0500 BioMedReports has published a new blog post: Celldex Therapeutics (NASDAQ: CLDX): Plenty of Cash and Pending Clinical Catalysts.

]]> fc6745370d1dd731d79775aa52cb543b BioMedReports has published a new blog post: NF Energy (OTC: NFEC.OB): An Efficient China Growth Play. http://www.blogcatalog.com/post/78310e6c4aefd2e93affff0ab94b9879 Sat, 17 Oct 2009 18:22:00 -0500 BioMedReports has published a new blog post: NF Energy (OTC: NFEC.OB): An Efficient China Growth Play.

]]> 19912c699bb30d1c3992aadada9c7eaa BioMedReports has published a new blog post: FDA Approves Glaxo’s (NYSE: GSK) Cervical Cancer Vaccine. http://www.blogcatalog.com/post/57817392e3ec8f3b41b972f8fec73846 Fri, 16 Oct 2009 09:59:00 -0500 BioMedReports has published a new blog post: FDA Approves Glaxo’s (NYSE: GSK) Cervical Cancer Vaccine.

]]> 42ce72b598a260a0911f47ce6d1671ba BioMedReports has published a new blog post: BioMed News Bytes: Cytori (NASDAQ: CYTX), Questcor (NASDAQ: QCOR). http://www.blogcatalog.com/post/788e4fec87ddc4e4afdbf2fa219ddb7c Thu, 15 Oct 2009 20:14:00 -0500 BioMedReports has published a new blog post: BioMed News Bytes: Cytori (NASDAQ: CYTX), Questcor (NASDAQ: QCOR).

]]> 27568150bded8d7b8cec912ea3c4d31c BioMedReports has published a new blog post: October FDA Calendar Stocks: Tricks or Treats?. http://www.blogcatalog.com/post/8f25d678c491d378734a4a94c19b8e76 Thu, 15 Oct 2009 11:53:00 -0500 BioMedReports has published a new blog post: October FDA Calendar Stocks: Tricks or Treats?.

]]> 7423bf5e3022d624a85b8b603cca5008 BioMedReports has published a new blog post: BioMed News Bytes: Protalix, Soligenix. http://www.blogcatalog.com/post/654565dce2ef661f6923639614bfbc1e Thu, 15 Oct 2009 09:36:00 -0500 BioMedReports has published a new blog post: BioMed News Bytes: Protalix, Soligenix.

]]> 8982f6973399460ec0721dba2b663d04 BioMedReports has published a new blog post: BioDelivery Sciences (NASDAQ: BDSI): Restarting the Catalyst Cycle. http://www.blogcatalog.com/post/eb199d48f0c284a3adf5467df7d5fdca Thu, 15 Oct 2009 09:17:00 -0500 BioMedReports has published a new blog post: BioDelivery Sciences (NASDAQ: BDSI): Restarting the Catalyst Cycle.

]]> 9d0de375f3aa73b840033dc4f60f0f03 BioMedReports has published a new blog post: Access Pharma (OTC: ACCP.OB): Clinical, Commercial MuGard Updates. http://www.blogcatalog.com/post/278e8aecc1fc5f923c89dab2a48e3cfd Thu, 15 Oct 2009 07:47:00 -0500 BioMedReports has published a new blog post: Access Pharma (OTC: ACCP.OB): Clinical, Commercial MuGard Updates.

]]> 44fc83717366a0bf61aced4d0cd94578 BioMedReports has published a new blog post: A Positive FDA Panel Outcome for Acorda Therapeutics (NASDAQ: ACOR). http://www.blogcatalog.com/post/fd376f0e76d396027620f1d93ea45442 Wed, 14 Oct 2009 19:10:00 -0500 BioMedReports has published a new blog post: A Positive FDA Panel Outcome for Acorda Therapeutics (NASDAQ: ACOR).

]]> c0d198b217113ef99f2c936b07d1dd3b BioMedReports has published a new blog post: BioMed News Bytes: IntelGenx, Pressure BioSciences. http://www.blogcatalog.com/post/8b867d91912c8ec9b5472c64788a2c3e Wed, 14 Oct 2009 10:46:00 -0500 BioMedReports has published a new blog post: BioMed News Bytes: IntelGenx, Pressure BioSciences.

]]> 92793756dc7d6e353977fc3703caccb6 BioMedReports has published a new blog post: BioMed News Bytes: PGNX, SMTS, ZIOP, CXM, PSDV, BMTI. http://www.blogcatalog.com/post/546d147a3aeafdd10bd506776b76a7bf Wed, 14 Oct 2009 09:09:00 -0500 BioMedReports has published a new blog post: BioMed News Bytes: PGNX, SMTS, ZIOP, CXM, PSDV, BMTI.

]]> ce4fbfc566142dcd742dc271358b00da BioMedReports has published a new blog post: Rockwell Medical (NASDAQ: RMTI) Initiated at Outperform, $12 Target. http://www.blogcatalog.com/post/b13cf8e0aff4d6a7fa8085effb7aa241 Tue, 13 Oct 2009 12:24:00 -0500 BioMedReports has published a new blog post: Rockwell Medical (NASDAQ: RMTI) Initiated at Outperform, $12 Target.

]]> f461ffbc320d2c4db9fdf9603917b8fa BioMedReports has published a new blog post: DATATRAK: Low Valuation, Improving Results. http://www.blogcatalog.com/post/ec6fd3e28df025f4d62e5ec26233138a Tue, 13 Oct 2009 11:50:00 -0500 BioMedReports has published a new blog post: DATATRAK: Low Valuation, Improving Results.

]]> 5a2625c2705ecc735d98cd2d2cd1b051 BioMedReports has published a new blog post: FDA Calendar Extreme Trades: 85 Single Digit Stocks. http://www.blogcatalog.com/post/05b65efa7c1d2ac66e5185d0bf02e6f6 Tue, 13 Oct 2009 10:48:00 -0500 BioMedReports has published a new blog post: FDA Calendar Extreme Trades: 85 Single Digit Stocks.

]]> 9a2caec11e25dfad181b54576461b302 BioMedReports has published a new blog post: Inovio Biomedical (AMEX: INO): A DNA Vaccine Delivery Innovator. http://www.blogcatalog.com/post/f32eaae2adf40c4bf463ebac682e77f0 Thu, 08 Oct 2009 09:24:00 -0500 BioMedReports has published a new blog post: Inovio Biomedical (AMEX: INO): A DNA Vaccine Delivery Innovator.

]]> 4e949d9e629d750380f8daae8016ff84 BioMedReports has published a new blog post: A Three-Part China Merger Strategy for NeoStem (AMEX: NBS). http://www.blogcatalog.com/post/db72a0d228a9a0bc2349d00ea758ef86 Wed, 07 Oct 2009 19:53:00 -0500 BioMedReports has published a new blog post: A Three-Part China Merger Strategy for NeoStem (AMEX: NBS).

]]> 5fdebb04dc29ee1e329922e3706cbf72 BioMedReports has published a new blog post: Momenta Pharma: Timing Uncertain, Approval Likely for M-Enoxaparin. http://www.blogcatalog.com/post/4802d29ecb70fae8e966613e311daf80 Tue, 06 Oct 2009 13:38:00 -0500 BioMedReports has published a new blog post: Momenta Pharma: Timing Uncertain, Approval Likely for M-Enoxaparin.

]]> 52c3c2c00290257845f4226e8adb7f14 BioMedReports has published a new blog post: Protox Therapeutics: A Molecular Approach to Surgery. http://www.blogcatalog.com/post/6ec9a5086903ae9c60eb7808ddbbeba7 Tue, 06 Oct 2009 09:06:00 -0500 BioMedReports has published a new blog post: Protox Therapeutics: A Molecular Approach to Surgery.

]]> 607c499377182e7f2c9de306b4d6227e BioMedReports has published a new blog post: Access Pharma, iMedicor Sign e-Marketing Deal for MuGard. http://www.blogcatalog.com/post/c303c857531f7e06f0cf1d4bb8beb59d Tue, 06 Oct 2009 07:37:00 -0500 BioMedReports has published a new blog post: Access Pharma, iMedicor Sign e-Marketing Deal for MuGard.

]]> f31a7c9a308639611fe54e1c376aac67 BioMedReports has published a new blog post: BioMed News Bytes: Cytori, EXACT Sciences, HEPI. http://www.blogcatalog.com/post/ddee9696a6aa80b3ccdb9c510cbf900f Sat, 03 Oct 2009 12:59:00 -0500 BioMedReports has published a new blog post: BioMed News Bytes: Cytori, EXACT Sciences, HEPI.

]]> e8b55102a1c23ba6a026e2c3ff3abd3a BioMedReports has published a new blog post: NeoPharm (OTC: NEOL.PK): A Pipeline with Multiple Catalysts. http://www.blogcatalog.com/post/5428ab3d3798595d52d4538b44451674 Fri, 02 Oct 2009 17:37:00 -0500 BioMedReports has published a new blog post: NeoPharm (OTC: NEOL.PK): A Pipeline with Multiple Catalysts.

]]> 1ec7281a3307329a5321ddca3d509f23 BioMedReports has published a new blog post: ImmunoCellular (OTC: IMUC.OB): Updated Presentation, Pending Catalysts. http://www.blogcatalog.com/post/14bae63e52913ea9698afd21c94109e5 Fri, 02 Oct 2009 08:54:00 -0500 BioMedReports has published a new blog post: ImmunoCellular (OTC: IMUC.OB): Updated Presentation, Pending Catalysts.

]]> af62fb68faeab94829d7bf5b04a7b75a BioMedReports has published a new blog post: ImmunoCellular (OTC: IMUC.OB): Delivering on Key Milestones. http://www.blogcatalog.com/post/23e2e4b252027a4364468d4c56140153 Wed, 30 Sep 2009 07:24:00 -0500 BioMedReports has published a new blog post: ImmunoCellular (OTC: IMUC.OB): Delivering on Key Milestones.

]]> 643402f9b2dbc6b0b93ab812ccad7fae BioMedReports has published a new blog post: Small-Cap Stocks Battling Brain Cancer. http://www.blogcatalog.com/post/9274e32c301b0b09991510a587310a26 Sun, 06 Sep 2009 12:40:35 -0500 BioMedReports has published a new blog post: Small-Cap Stocks Battling Brain Cancer.

]]> 35fa29abe62e743f8ca877ad83ed2c11 BioMedReports has published a new blog post: Mentor Capital (PINK:MNTR): A Risk-Mitigated Call Option on QI's Cancer Immunotherapy. http://www.blogcatalog.com/post/037851eb0e328eae481b23ec732f8a3a Wed, 02 Sep 2009 04:48:08 -0500 BioMedReports has published a new blog post: Mentor Capital (PINK:MNTR): A Risk-Mitigated Call Option on QI\'s Cancer Immunotherapy.

]]> 6e1117a6963b937a009f36a52ce6c808 BioMedReports has published a new blog post: Lixte Biotech (OTC:LIXT): Preclinical Enhancement of Anti-Cancer Treatments. http://www.blogcatalog.com/post/cc99d37985084ec661cc10ada8ce48ac Wed, 02 Sep 2009 04:44:30 -0500 BioMedReports has published a new blog post: Lixte Biotech (OTC:LIXT): Preclinical Enhancement of Anti-Cancer Treatments.

]]> 2d9e98f897f6ece5694a1c6e091e1f63 BioMedReports has published a new blog post: Rockwell Medical (NASDAQ:RMTI): Early-Stage AMAG Growth Potential. http://www.blogcatalog.com/post/8d5aeebd083ea55872727864314f106e Wed, 02 Sep 2009 04:41:12 -0500 BioMedReports has published a new blog post: Rockwell Medical (NASDAQ:RMTI): Early-Stage AMAG Growth Potential.

]]> 6e38e956c046d7077a5df7738c3e5d37 BioMedReports has published a new blog post: ImmunoCellular (OTC:IMUC): A New Paradigm in Cancer Treatment. http://www.blogcatalog.com/post/f070bbc630bbf79c65f99049f4f2be9a Wed, 02 Sep 2009 04:38:54 -0500 BioMedReports has published a new blog post: ImmunoCellular (OTC:IMUC): A New Paradigm in Cancer Treatment.

]]>